Emcure Pharmaceuticals Ltd.
EMCURE
Peringkat dalam Saham
#4333
Emcure Pharmaceuticals Limited is committed to providing high-quality,... Emcure Pharmaceuticals Limited is committed to providing high-quality, cost-effective healthcare solutions to a global market. The company boasts a diverse product lineup spanning numerous medical fields, such as women's health (gynecology), anti-infectives, pain relief, nutritional supplements (vitamins, minerals, and nutrients), hematology, oncology, respiratory treatments, HIV antivirals, gastrointestinal remedies, anti-diabetics, neurological medications, and cardiovascular therapies. Notable brand names under their umbrella include Orofer XT, Tenectase, Pause, Metpure XL, Vylda, Vitanova, and Proxym. Founded in 1981, Emcure Pharmaceuticals Limited is headquartered in Pune, India.
Harga Saham
$18.81
Kapitalisasi Pasar
$3.57B
Perubahan (1 hari)
-3.13%
Perubahan (1 tahun)
18.91%
Negara
IN
Perdagangan Emcure Pharmaceuticals Ltd. (EMCURE)
Kategori
Healthcare
Riwayat harga saham Emcure Pharmaceuticals Ltd. (EMCURE)
Harga penutupan tertinggi: $20.40 pada 2026-10-01
Harga penutupan terendah: $15.91 pada 2024-07-01
Harga penutupan terendah: $15.91 pada 2024-07-01
Riwayat harga saham Emcure Pharmaceuticals Ltd. dari 2024 hingga 2026
Performa harga saham tahunan
| Tahun | Performa |
|---|---|
| 2026 (TTM) | 16.96% |
| 2025 | -4.84% |
| 2024 | 0.00% |
Harga saham perusahaan atau pesaing serupa
| Perusahaan | Harga saham | Perubahan 1th% | Negara |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $165.31 | 23.62% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $224.81 | 31.28% |
CH
|
|
| $18.43 | -4.03% |
IN
|
